isoxazoles has been researched along with Spondylarthropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-González, R; Martín-Martínez, MA; Pérez-Vicente, S; Silva-Fernández, L | 1 |
| Barde, C; Borradori, L; Janer, V; Saurat, JH; Thielen, AM | 1 |
| Bodur, H; Ergül, G; Eser, F; Seçkin, S; Seçkin, U | 1 |
3 other study(ies) available for isoxazoles and Spondylarthropathies
| Article | Year |
|---|---|
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Humans; Inflammatory Bowel Diseases; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Odds Ratio; Practice Patterns, Physicians'; Psoriasis; Retrospective Studies; Severity of Illness Index; Sex Factors; Spain; Spondylarthropathies; Sulfasalazine; Uveitis | 2015 |
Reiter syndrome triggered by adalimumab (Humira) and leflunomide (Arava) in a patient with ankylosing spondylarthropathy and Crohn disease.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Reactive; Crohn Disease; Humans; Isoxazoles; Leflunomide; Male; Spondylarthropathies | 2007 |
Coexistence of familial Mediterranean fever and psoriasis in a patient with seronegative spondyloarthropathy.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Colchicine; Drug Therapy, Combination; Familial Mediterranean Fever; Gout Suppressants; Health Status; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Male; Severity of Illness Index; Spondylarthropathies; Treatment Outcome | 2008 |